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A B S T R A C T
TB mathematical models employ various assumptions and approaches in dealing with the heterogeneous in-
fectiousness of persons with active TB. We reviewed existing approaches and considered the relationship be-
tween them and existing epidemiological evidence.
We searched the following electronic bibliographic databases from inception to 9 October 2018: MEDLINE,
EMBASE, Biosis, Global Health and Scopus. Two investigators extracted data using a standardised data ex-
traction tool. We included in the review any transmission dynamic model of M. tuberculosis transmission ex-
plicitly simulating heterogeneous infectiousness of person with active TB. We extracted information including:
study objective, model structure, number of active TB compartments, factors used to stratify the active TB
compartment, relative infectiousness of each active TB compartment and any intervention evaluated in the
model.
Our search returned 1899 unique references, of which the full text of 454 records were assessed for eligibility,
and 99 studies met the inclusion criteria. Of these, 89 used compartmental models implemented with ordinary
differential equations, while the most common approach to stratification of the active TB compartment was to
incorporate two levels of infectiousness. However, various clinical characteristics were used to stratify the active
TB compartments, and models differed as to whether they permitted transition between these states. Thirty-four
models stratified the infectious compartment according to sputum smear status or pulmonary involvement,
while 18 models stratified based on health care-related factors. Variation in infectiousness associated with drug-
resistant M. tuberculosis was the rationale for stratifying active TB in 33 models, with these models consistently
assuming that drug-resistant active TB cases were less infectious.
Given the evidence of extensive heterogeneity in infectiousness of individuals with active TB, an argument
exists for incorporating heterogeneous infectiousness, although this should be considered in light of the objec-
tives of the study and the research question.
PROSPERO Registration: CRD42019111936.
1. Introduction
Tuberculosis (TB) is one of the top ten causes of death and the
leading cause from a single infectious agent (WHO, 2018). Although the
disease burden caused by TB is falling globally, we are unlikely to see
the first milestones of the End TB Strategy achieved in 2020 (WHO,
2014). The current global burden of TB is not homogeneously
distributed across populations, but rather is an aggregate of localised
micro-epidemics, with this heterogeneous distribution likely to become
more prominent as disease burden decreases (Pai et al., 2016). One of
several factors that contributes to the heterogeneity of Mycobacterium
tuberculosis (Mtb) transmission in a given population is the intrinsic
variation in the infectiousness of individuals with active TB (Trauer
et al., 2018). The heterogeneous infectiousness of such individuals has
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been established from both epidemiologic contact investigations and
genotypic data (Ypma et al., 2013; Melsew et al., 2019). These studies
have demonstrated that a very few highly infectious individuals with
active TB are responsible for a large proportion of onward transmission,
while a much larger proportion of individuals have very low or negli-
gible infectiousness. As this heterogeneity has effects on the basic re-
production number, Ro, and the impact of interventions, incorporating
heterogeneous infectiousness assumptions in TB transmission dynamic
models may be critical depending on the modelling objectives (Trauer
et al., 2018).
Transmission dynamic models typically have one of two broad
purposes: either to improve understanding of the behaviour of the
epidemic, or to make predictions of disease burden, including under
counterfactual intervention strategy scenarios. Any such models should
represent reality as accurately as possible, while also considering the
need for model parsimony, although the optimal balance of these fac-
tors is dependent on judgement and epidemiological understanding
(McLean, 2013; Cohen and White, 2016). Though the first TB model
was published more than half a century ago (Waaler et al., 1962), TB
models continue to differ in their assumptions due to imperfect un-
derstanding of the complex natural history of TB and lack of available
data on the clinical progression of individuals through their stages of
disease.
By systematically reviewing previous TB transmission modelling
studies, we describe existing methods used to capture heterogeneity in
infectiousness of individuals with active TB. Specifically, we aimed to
identify all TB transmission models that explicitly stratified the active
TB compartment by levels of infectiousness, and to understand their
modelling assumptions and parameter choices.
2. Methods
We reviewed all published TB mathematical modelling studies that
considered heterogeneity in infectiousness, with infectiousness con-
ceptually defined as the number of secondary infections resulting from
an individual with active disease per unit time. The review protocol was
prospectively registered with PROSPERO (International Prospective
Register of Systematic Reviews, registration number:
CRD42019111936) and can be accessed at https://www.crd.york.ac.
uk/prospero/display_record.php?RecordID=111,936). We adhered to
the Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) guidelines throughout (Liberati et al., 2009) and the
PRISMA checklist is provided in Appendix A in Supplementary mate-
rial.
2.1. Search strategy
Before starting the review, we searched for systematic reviews that
assessed methods used to capture heterogeneity in infectiousness of
individuals with active TB in transmission dynamic models, with no
such reviews found.
We searched the following electronic bibliographic databases from
inception to 9 October 2018: MEDLINE, EMBASE, Biosis, Global Health
and Scopus for studies in human subjects published in English. All
search terms were “exploded” to capture all resources and consisted of
“TB”, “Tuberculosis”, “Mycobacterium tuberculosis”, “Dynamic
model”, “Transmission dynamics”, “Simulation”. Full search strategy is
provided in Appendix B in Supplementary material.
2.2. Study selection
Search results were exported to EndNoteX8.2 (Clarivate Analytics,
NY, USA) and duplicates were removed. Titles and abstracts were
screened to identify potentially relevant articles. After initial screening
for any TB modelling studies, the full texts of eligible articles were
collected and assessed for eligibility. Included studies consisted of any
transmission dynamic TB modelling study explicitly incorporating the
assumption of heterogeneous infectiousness of individuals with active
TB. Studies were excluded if they were systematic reviews, did not
employ mathematical models, did not model Mtb, were intra-host
models or assumed homogeneous infectiousness.
2.3. Assessment of quality
As we aimed to assess the diverse methods used to capture hetero-
geneous infectiousness of individuals with active TB and there was no
epidemiological pooling, risk of bias assessment was not performed.
2.4. Data extraction and analysis
Data were extracted using a standardised data extraction tool de-
veloped, tested and approved by four investigators (YAM, AIA, RR and
JMT). Full manuscripts and supplementary material accompanying the
main texts of each article were reviewed. YAM and AIA extracted data
and any controversies in interpretation were resolved by consensus.
We extracted general information that included: year of publication,
study setting, study objective, model structure, and information about
our main objective, including: the number of infectious compartments,
factors used to stratify the infectious compartment and the relative
infectiousness of each active compartment.
3. Results
Our search strategy returned 1899 unique references, of which the
full text of 454 records were assessed for eligibility, and 99 studies met
the inclusion criteria of explicitly capturing heterogeneous infectious-
ness (Fig. 1). Of the 99 included TB models, 89 were compartmental
models implemented using ordinary differential equations, one study
used both ordinary and partial differential equations and the remaining
nine were individual-based models (IBM). Included studies spanned
many different epidemiological settings: 25 studies were from Asia or
the Asia-Pacific, 21 were from sub-Saharan Africa, 12 studies were from
Europe or North America. Nineteen studies represented hypothetical
settings based on TB burden, economic development or HIV prevalence.
Eight of these models were from high TB-burden settings (or “low/
middle income”), two were from low TB burden settings (or “the de-
veloped world”), two were from high HIV prevalence settings and one
aimed to represent global TB epidemiology.
3.1. Aims of models
The broad objectives of most included TB models were to evaluate
the impact of various intervention strategies and make predictions of
future disease burden based on various settings and scenarios. Forty-
four of the 99 models were designed to estimate the likely impact of
currently available interventions (Tuite et al., 2017; Vynnycky et al.,
2015; Trauer et al., 2016a; Okuonghae and Aihie, 2008; Okuonghae
and Ikhimwin, 2016; Okuonghae and Korobeinikov, 2007; Okuonghae
and Omosigho, 2011; Rayhan and Bakhtiar, 2017; Sachdeva et al.,
2015; Salje et al., 2014; Salomon et al., 2006; Sharomi et al., 2008;
Suen et al., 2014; Thomas et al., 2010; Hickson et al., 2011; Hickson
et al., 2012; Hill et al., 2012; Hughes et al., 2006; Huynh et al., 2015;
Jung et al., 2002; Kendall et al., 2015; Knight et al., 2015; Liao and Lin,
2012; Mellor et al., 2011; Menzies et al., 2012; Moualeu et al., 2015;
Bowong and Alaoui, 2013; Dowdy et al., 2014; Dowdy et al., 2013a;
Dowdy and Chaisson, 2009; Dowdy et al., 2008; Dowdy et al., 2006;
Dowdy et al., 2013b; Dowdy et al., 2013c; Dye and Williams, 2008;
Espindola et al., 2012; Fofana et al., 2017; Garcia et al., 1997; Gomes
et al., 2007; Guzzetta et al., 2011; Bacaer et al., 2008; Basu et al., 2007;
Basu et al., 2009; Bhunu and Garira, 2009), while five models evaluated
the potential impact of interventions that were new, under develop-
ment or hypothetical (Abu-Raddad et al., 2009; Knight et al., 2014; Lin
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et al., 2012; Sun et al., 2013; Trauer et al., 2016b). Twenty-one models
were built to capture TB epidemiology in a specific setting and make
predictions by using local data (Arregui et al., 2018; Blower et al., 1995;
Herrera et al., 2013; Houben et al., 2016; Legrand et al., 2008; Liao
et al., 2012; Liao et al., 2013; Liu et al., 2011; Melnichenko and
Romanyukha, 2009; Menzies et al., 2018; Moualeu et al., 2014;
Moualeu-Ngangue et al., 2015; Mushayabasa and Bhunu, 2013;
Nishiura et al., 2004; Oxlade et al., 2011; Pandey et al., 2017; Perelman
et al., 2004; Sun et al., 2011; Wu et al., 2010; Zhang et al., 2015). Eight
models were more theoretically focused, aiming to draw general con-
clusions about transmission dynamics, such as determining equilibrium
points or reproductive numbers, and in some cases undertaking stability
or sensitivity analyses around these quantities (Houben et al., 2016;
Apriliani et al., 2016; Blower and Gerberding, 1998; Cohen and Murray,
2004; Liu et al., 2008; Liu and Sun, 2010; McBryde et al., 2017; Trauer
et al., 2014). Four models assessed the impact of risk factors, such as
smoking, age and diabetes mellitus (Garcia et al., 1997; Bhunu et al.,
2011; Moualeu et al., 2012; Rodrigues et al., 2015), three evaluated the
impact of immigration (Korthals Altes et al., 2018; Moualeu et al.,
2018; Okuonghae and Aihie, 2010), and two evaluated the impact of
Mtb re-infection (Moualeu et al., 2016; Sharomi et al., 2017). Six
models additionally assessed aspects of the MDR-TB epidemic and its
control (Kendall et al., 2015; Agusto et al., 2015; Ahmadin and
Fatmawati, 2014; Bishai et al., 2010; Raimundo et al., 2014; Shrestha
et al., 2014).
Models stratified the active TB compartment according to the level
of infectiousness for a range of reasons, the commonest being to capture
the impact of interventions directed at specific sub-groups of in-
dividuals with active TB or that had differential effectiveness depending
on the level of infectiousness. Within this group, forty-three models
stratified the active TB compartment in order to capture the impact of
detection and treatment interventions (Tuite et al., 2017; Vynnycky
et al., 2015; Okuonghae and Korobeinikov, 2007; Rayhan and Bakhtiar,
2017; Sachdeva et al., 2015; Salje et al., 2014; Salomon et al., 2006;
Sharomi et al., 2008; Suen et al., 2014; Thomas et al., 2010; Huynh
et al., 2015; Jung et al., 2002; Knight et al., 2015; Mellor et al., 2011;
Bowong and Alaoui, 2013; Dowdy et al., 2014; Dowdy et al., 2013a;
Dowdy and Chaisson, 2009; Dowdy et al., 2008; Dowdy et al., 2006;
Dowdy et al., 2013b; Dowdy et al., 2013c; Fofana et al., 2017; Garcia
et al., 1997; Basu et al., 2007; Basu et al., 2009; Bhunu and Garira,
2009; Abu-Raddad et al., 2009; Lin et al., 2012; Sun et al., 2013; Trauer
et al., 2016b; Legrand et al., 2008; Nishiura et al., 2004; Perelman et al.,
2004; Blower and Gerberding, 1998; Liu et al., 2008; Liu and Sun,
2010; Korthals Altes et al., 2018; Okuonghae and Aihie, 2010; Agusto
et al., 2015; Huo and Zou, 2016; Kendall et al., 2017; Osgood et al.,
2011). By contrast, forty-four models incorporated stratification in the
process of estimating key parameters in TB epidemiology, such as the
number of secondary infections per infectious individual and Ro
(Trauer et al., 2016a; Okuonghae and Aihie, 2008; Okuonghae and
Ikhimwin, 2016; Okuonghae and Omosigho, 2011; Hickson et al., 2011;
Hickson et al., 2012; Hughes et al., 2006; Liao and Lin, 2012; Menzies
et al., 2012; Moualeu et al., 2015; Gomes et al., 2007; Guzzetta et al.,
2011; Bacaer et al., 2008; Blower et al., 1995; Herrera et al., 2013; Liao
et al., 2012; Liao et al., 2013; Melnichenko and Romanyukha, 2009;
Menzies et al., 2018; Moualeu et al., 2014; Moualeu-Ngangue et al.,
2015; Mushayabasa and Bhunu, 2013; Oxlade et al., 2011; Pandey
et al., 2017; Zhang et al., 2015; Apriliani et al., 2016; Cohen and
Murray, 2004; McBryde et al., 2017; Trauer et al., 2014; Bhunu et al.,
Fig. 1. Flow diagram of study selection process.
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2011; Moualeu et al., 2012; Moualeu et al., 2018; Moualeu et al., 2016;
Sharomi et al., 2017; Ahmadin and Fatmawati, 2014; Raimundo et al.,
2014; Aparicio and Castillo-Chavez, 2009; Kasaie and Dowdy, 2013; Li
et al., 2011; Nyabadza and Kgosimore, 2012; Okuonghae, 2013). Eight
models also stratified the active TB compartment to predict the future
proportion of each type of TB simulated (Kendall et al., 2015; Espindola
et al., 2012; Arregui et al., 2018; Sun et al., 2011; Wu et al., 2010;
Rodrigues et al., 2015; Bishai et al., 2010; Shrestha et al., 2014). In a
further six models, the rationale for stratifying the active TB compart-
ment was not explained (Hill et al., 2012; Dye and Williams, 2008;
Knight et al., 2014; Trauer et al., 2016b; Houben et al., 2016; Ackley
et al., 2015).
3.2. Model structures
Models most commonly presented the natural history of TB using
Susceptible, Exposed, Infectious, Recovered (SEIR) compartmental
structures, although SEI, SEIS and SEIE structures were also used.
(Some of these models employed more than one latency compartment;
thus, “E” may represent multiple latency compartments.) In our review,
the majority (64) of the models adopted a SEIR compartmental struc-
ture, while 12 used SEI structures and 11 employed SEIS.
The structures used by TB models to stratify the active TB com-
partment according to infectiousness level varied between models, with
most models employing two active TB compartments. Fig. 2 presents a
summary of the compartmental structures used and Table 1 maps the
specific models to the compartmental structure employed. Henceforth,
we refer to the specific model structures by the alphabetical structure
names introduced in Fig. 2. It is important to note that several of these
classifications include models that use the same compartmental
structure, but use these structures to represent different factors (and so
employ different parameter values). Stratifying the active TB com-
partment into two unconnected infectiousness levels (Structure A) was
the commonest structure used, followed by a structure employing two
infectious levels and with an additional transition process linking these
two states (Structure B).
3.3. Factors for stratification
TB models stratified the active TB compartment by infectiousness in
order to capture a range of clinical characteristics. These factors in-
cluded: factors related to characteristics of the host, such as disease
manifestation, co-morbidities and age; factors related to the organism,
i.e. impaired fitness ofMtb due to drug resistance mutations; and factors
related to the health care system. The factors used for stratification of
the active TB compartment were sometimes combined in the included
studies and are not mutually exclusive.
3.3.1. Factors related to disease characteristics
3.3.1.1. Pulmonary involvement. Six TB models explicitly classified the
active TB compartment based on the clinical site of TB disease, as either
representing cases with lung involvement (pulmonary TB), or with
disease limited only to body organs other than the lungs
(extrapulmonary TB) (Thomas et al., 2010; Hickson et al., 2012; Dye
and Williams, 2008; Korthals Altes et al., 2018; Aparicio and Castillo-
Chavez, 2009). These models universally assumed that only pulmonary
TB cases were infectious without further stratification by smear-status.
Five of these models employed Structure A (Thomas et al., 2010;
Hickson et al., 2012; Mellor et al., 2011; Dye and Williams, 2008;
Korthals Altes et al., 2018; Aparicio and Castillo-Chavez, 2009), while
one model also incorporated conversion from non-infectious to
infectious TB (Structure B) (Mellor et al., 2011).
3.3.1.2. Sputum smear-status. Sputum smear-status was a commonly
used factor for stratifying active TB cases into varying levels of
infectiousness. Twenty-two TB models stratified the active TB
compartment by sputum smear-status (Tuite et al., 2017; Vynnycky
et al., 2015; Menzies et al., 2012; Dowdy et al., 2014; Dowdy and
Chaisson, 2009; Dowdy et al., 2008; Dowdy et al., 2006; Dowdy et al.,
2013b; Dowdy et al., 2013c; Garcia et al., 1997; Gomes et al., 2007;
Guzzetta et al., 2011; Abu-Raddad et al., 2009; Knight et al., 2014; Lin
et al., 2012; Sun et al., 2013; Arregui et al., 2018; Houben et al., 2016;
Menzies et al., 2018; Oxlade et al., 2011; Pandey et al., 2017; Ackley
et al., 2015), of which eleven characterised active TB as either smear-
positive or smear-negative TB (with smear-negative TB always
considered less infectious). Among these models, seven employed
Structure A (Dowdy et al., 2013b; Gomes et al., 2007; Knight et al.,
2014; Lin et al., 2012; Oxlade et al., 2011; Pandey et al., 2017; Ackley
et al., 2015), while the remaining used Structure B to incorporate a
transition from smear-negative to smear-positive (Tuite et al., 2017;
Menzies et al., 2012; Garcia et al., 1997; Houben et al., 2016; Menzies
et al., 2018), thereby assuming that some smear-positive individuals
must have initially been smear-negative at disease onset.
Employing Structure E, TB models used a three-tier stratification
incorporating pulmonary involvement and smear-status to divide the
active TB compartment into smear-positive TB, smear-negative TB and
extrapulmonary TB (non-infectious) (Dowdy et al., 2014; Dowdy et al.,
2013c; Abu-Raddad et al., 2009; Arregui et al., 2018). Five models
included four active TB compartments, four of which used detection
status to further cross-stratify smear-positive and TB smear-negative,
while one model cross-stratified HIV status and smear-status (Vynnycky
et al., 2015; Dowdy and Chaisson, 2009; Dowdy et al., 2008; Dowdy
et al., 2006; Sun et al., 2013). Under each of these approaches, in-
fectiousness was influenced by smear status, such that smear-positive
individuals were considered more infectious than those smear-negative.
Twenty-one of the 22 models that stratified the active TB
Fig. 2. Structures for the infectious compartments used by TB models that in-
corporate multiple levels of infectiousness. L: latent infection, I: active TB, with
subscripts to indicate the multiple infectious compartments. Some of these
models used more than one compartment for latency, thus “L” may represent
multiple latency compartments here. The subscript numbers to the “I” com-
partments are arbitrary.
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compartment by smear-status considered both smear-positives and
smear-negatives to be infectious, with smear-negatives having a lower
level of infectiousness. The parameterisation for the relative in-
fectiousness of smear-negative individuals compared to smear-positive
was highly consistent across multiple modelling studies and almost
universally fell in the range of 15–25%. Only one model that assessed
the impact of changes in TB programs in low prevalence setting was an
exception and assumed smear-negatives to be non-infectious (Garcia
et al., 1997). Table 2 presents proportions and relative infectiousness of
active TB compartments among models that incorporated two levels of
infectiousness based on pulmonary involvement or smear status.
3.3.1.3. Type of infection. A model employing Structure A stratified
active TB based on history of previous infection, as symptomatic
primary infection or symptomatic re-infection, with the assumption
that re-infected individuals were twice as infectious as primarily
infected counterparts (Sharomi et al., 2017). An IBM further
subdivided smear-positive and smear-negative TB into three groups
based on the timing of disease onset from infection; namely primary TB,
endogenous reactivation, and exogenous re-infection. However, under
this approach the level of infectiousness was dependent only on smear-
status, with smear-positive individuals four-times as infectious as
smear-negatives (Guzzetta et al., 2011).
3.3.1.4. Stage of disease. A theoretical model of heterogeneous
progression sub-divided the active TB compartment according to
Table 1
Infectious compartment structures used by compartmental TB single strain models.
Structure Number of studies Citation
A 27 (Okuonghae and Aihie, 2008; Okuonghae and Ikhimwin, 2016; Okuonghae and Korobeinikov, 2007; Okuonghae and Omosigho, 2011; Sharomi
et al., 2008; Hill et al., 2012; Bowong and Alaoui, 2013; Dowdy et al., 2006; Dowdy et al., 2013b; Dowdy et al., 2013c; Dye and Williams, 2008;
Gomes et al., 2007; Lin et al., 2012; Blower et al., 1995; Herrera et al., 2013; Liao et al., 2012; Liao et al., 2013; Oxlade et al., 2011; Pandey et al.,
2017; Zhang et al., 2015; Apriliani et al., 2016; Korthals Altes et al., 2018; Okuonghae and Aihie, 2010; Sharomi et al., 2017; Aparicio and
Castillo-Chavez, 2009; Okuonghae, 2013; Ackley et al., 2015)
B 11 (Hughes et al., 2006; Menzies et al., 2012; Garcia et al., 1997; Bacaer et al., 2008; Knight et al., 2014; Houben et al., 2016; Menzies et al., 2018;
Moualeu et al., 2014; Bhunu et al., 2011; Moualeu et al., 2012; Moualeu et al., 2018)
C 1 (Huo and Zou, 2016)
D 2 (Dowdy et al., 2014; Dowdy and Chaisson, 2009)
E 2 (Abu-Raddad et al., 2009; Arregui et al., 2018)
F 2 (Dowdy et al., 2013a; Mushayabasa and Bhunu, 2013)
G 3 (Vynnycky et al., 2015; Melnichenko and Romanyukha, 2009; Perelman et al., 2004)
H 1 (Wu et al., 2010)
I 1 (Legrand et al., 2008)
J 6 (Hickson et al., 2011; Hickson et al., 2012; Moualeu et al., 2015; Moualeu-Ngangue et al., 2015; Liu et al., 2008; Moualeu et al., 2016)
K 1 (Osgood et al., 2011)
Others 5 (Salomon et al., 2006; Thomas et al., 2010; Dowdy et al., 2008; Sun et al., 2013; Moualeu et al., 2012)
Table 2
Proportions and relative infectiousness of active TB compartments among models that use two levels of infectiousness based on lungs involvement or smear status.
Reference group.
Citation Active TB compartment Proportion progressing to high Relative infectious of
low
Conversion rate (low to high), per
year
High infectiousness Low infectiousness
(Ackley et al., 2015) Infectious Non-infectious 0.85 0 NA
(Aparicio and Castillo-Chavez,
2009)
Pulmonary Extrapulmonary 0.7 0 NA
(Blower et al., 1995) Infectious Non-infectious 0.5-0.85 0 NA
(Dye and Williams, 2008) Infectious Non-infectious 0.6 0 NA
(Gomes et al., 2007) Infectious Non-infectious 0.66-0.87 0 NA
(Herrera et al., 2013) Infectious Non-infectious 0.7-0.85 NA
(Liao et al., 2012) Infectious Non-infectious Normal distribution (0.78, 0.11) 0 NA
(Liao et al., 2013) Infectious Non-infectious Normal distribution (0.78, 0.11) 0 NA
(Thomas et al., 2010) Infectious Non-infectious HIV+=0.87 0 NA
HIV-=0.57
(Hughes et al., 2006) Infectious Non-infectious 0.64 0 0.015
(Knight et al., 2014) Infectious Non-infectious age< 15=0.1 0 0.015
age ≥15=0.5
(Dowdy et al., 2006)a Smear-positive Smear-negative HIV-=0.45 0.22 NA
HIV+=0.35
(Dowdy et al., 2013b)# Smear-positive Smear-negative HIV-=0.65 0.15 NA
HIV+=0.5
(Lin et al., 2012)# Smear-positive Smear-negative HIV- adult= 0.7, 0.22 NA
HIV+adult= 0.48
HIV- children= 0.17
HIV+ children= 0.1
(Oxlade et al., 2011) Smear-positive Smear-negative 0.5 0.2 NA
(Pandey et al., 2017) Smear-positive Smear-negative China, Korea, Philippines= 0.45
India=0.63
0.2 NA
(Garcia et al., 1997) Open cases Non-open cases 0.5 0 to non-openb
(Houben et al., 2016) Smear-positive Smear-negative 0.85 0.22 0.015
(Menzies et al., 2012) Smear-positive Smear-negative 0.62 0.17-0.3 0.012-0.019
a Although these models include multiple stratifications which influenced progression proportions, infectiousness was only dependent on smear status.
b Infectious cases convert to non-infectious cases at rate of diagnosis and treatment.
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progression time from infection to active TB, with fast progressors more
infectious than their slowly progressing counterparts (Okuonghae,
2013). A model evaluating case finding strategies employed modified
form of Structure F to stratify active TB into subclinical, pre-diagnostic
and clinical phases (Dowdy et al., 2013a), with infectiousness
increasing with progression between each of these three sequential
stages. Similarly, an IBM simulated infectiousness using a linear
function of time, with infectiousness increasing from zero to
maximum infectiousness over the first nine months of the disease
episode, and remaining unchanged thereafter (Kasaie and Dowdy,
2013).
3.3.2. Co-morbidities
Some models considered HIV co-infection and comorbid diabetes
mellitus to affect the level of infectiousness of individuals with active
TB. One model employed Structure B to stratify active TB based on HIV
status, assuming that individuals co-infected with HIV were less in-
fectious than HIV-negative (Bacaer et al., 2008). Using the same
structure, another model sub-divided the active TB compartment based
on diabetes status, assuming that individuals co-morbid with diabetic
were more infectious than their non-diabetic counterparts (Moualeu
et al., 2012). Smoking status was used in one model that assessed the
impact of smoking on TB transmission dynamics, with smokers assumed
to be more infectious (Bhunu et al., 2011).
3.3.3. Age
Twenty-three models incorporated age-specific infectiousness (Tuite
et al., 2017; Vynnycky et al., 2015; Suen et al., 2014; Hughes et al.,
2006; Huynh et al., 2015; Knight et al., 2015; Mellor et al., 2011;
Menzies et al., 2012; Dye and Williams, 2008; Garcia et al., 1997;
Guzzetta et al., 2011; Abu-Raddad et al., 2009; Knight et al., 2014;
Arregui et al., 2018; Houben et al., 2016; Liao et al., 2012; Liao et al.,
2013; Menzies et al., 2018; Wu et al., 2010; Rodrigues et al., 2015;
Osgood et al., 2011; Aparicio and Castillo-Chavez, 2009; Nyabadza and
Kgosimore, 2012). The great majority of these models assumed children
to be markedly less infectious than adults, although there were con-
siderable differences between models in the age categories chosen and
parameterisation.
Twenty-one of these models incorporated other factors in addition
to age, while the remaining two considered age as the only factor for
infectious heterogeneity. Of the models that considered age as the only
factor determining heterogeneous infectiousness, one stratified the ac-
tive TB compartment into adults and children, assuming that only
adults were infectious (Nyabadza and Kgosimore, 2012). The other
model of TB epidemics in a Chinese city employed Structure H taking
active TB cases of age 24 years as the reference group and assuming that
children were 81% less infectious relative to this group, while younger
adults were seven-times more infectious (Wu et al. (2010)).
3.3.4. Unspecified factors
Of all included models, eight classified the active TB compartment
as either infectious or non-infectious, but the rationale for this classi-
fication was often not explained (Hill et al., 2012; Hughes et al., 2006;
Knight et al., 2014; Blower et al., 1995; Herrera et al., 2013; Liao et al.,
2012; Liao et al., 2013; Apriliani et al., 2016). Among these models, two
(Hughes et al., 2006; Knight et al., 2014) employed Structure B, while
six (Hill et al., 2012; Blower et al., 1995; Herrera et al., 2013; Liao
et al., 2012; Liao et al., 2013; Apriliani et al., 2016) did not allow for
progression between the active TB compartments (Structure A).
3.3.5. Drug resistance
Variation in infectiousness associated with drug-resistant Mtb
strains was used to stratify active TB in 32 models (Trauer et al., 2016a;
Rayhan and Bakhtiar, 2017; Sachdeva et al., 2015; Salje et al., 2014;
Suen et al., 2014; Jung et al., 2002; Kendall et al., 2015; Liao and Lin,
2012; Espindola et al., 2012; Fofana et al., 2017; Basu et al., 2007; Basu
et al., 2009; Bhunu and Garira, 2009; Trauer et al., 2016b; Liu et al.,
2011; Nishiura et al., 2004; Sun et al., 2011; Blower and Gerberding,
1998; Cohen and Murray, 2004; Liu and Sun, 2010; McBryde et al.,
2017; Trauer et al., 2014; Rodrigues et al., 2015; Agusto et al., 2015;
Ahmadin and Fatmawati, 2014; Bishai et al., 2010; Raimundo et al.,
2014; Shrestha et al., 2014; Kendall et al., 2017; Li et al., 2011; De
Espíndola et al., 2011). In 31 of these models, cases with multidrug-
resistant TB (MDR-TB) were assumed less infectious than cases with
drug-susceptible TB (DS-TB), due to a fitness cost associated with the
resistance-conferring mutation. Most of these models considered in-
fectiousness of individuals with MDR-TB relative to individuals with
DS-TB to be around 0.8.
Eighteen of the 32 TB models used two active TB compartments to
represent DS-TB and MDR-TB without any additional stratification
(Rayhan and Bakhtiar, 2017; Suen et al., 2014; Jung et al., 2002; Liao
and Lin, 2012; Espindola et al., 2012; Fofana et al., 2017; Bhunu and
Garira, 2009; Liu et al., 2011; Nishiura et al., 2004; Blower and
Gerberding, 1998; Liu and Sun, 2010; Rodrigues et al., 2015; Agusto
et al., 2015; Ahmadin and Fatmawati, 2014; Bishai et al., 2010;
Raimundo et al., 2014; Shrestha et al., 2014; Li et al., 2011; De
Espíndola et al., 2011). Out of the three models that stratified active TB
into three compartments based on drug-susceptibility, with categories
being DS-TB, MDR-TB and extensively drug-resistant TB (XDR-TB) and
the assumption of a progressive gradient towards more resistant strains
being less infectious (Agusto et al., 2015). The second such model in-
corporated detection status to stratify active TB compartment into three
as undetected infectious TB, detected DS-TB and detected MDR-TB such
that the undetected cases were the most infectious followed by detected
MDR-TB. (Sun et al., 2011). The third model simulated active TB as
either: on ineffective treatment (a treatment course without curative
potential), on inadequate treatment (a treatment course with curative
potential but taken for an insufficient duration) and not on treatment.
This model assumed that individuals on ineffective or insufficient
treatment were less infectious than individuals not on treatment
(Fofana et al., 2017).
Six models integrated drug susceptibility with other factors, such as
stage of disease, detection and treatment status, to stratify active TB
into four compartments with varying levels of infectiousness (Trauer
et al., 2016a; Basu et al., 2007; Basu et al., 2009; McBryde et al., 2017;
Trauer et al., 2014; Kendall et al., 2017). For instance, a model of TB
dynamics in South Africa stratified TB as either infectious or non-in-
fectious and further sub-divided by drug susceptibility, assuming in-
dividuals with MDR-TB to be less infectious due to a resistance-asso-
ciated fitness cost (Basu et al., 2007). A model evaluating the impact of
diagnosis and treatment further stratified DS-TB and MDR-TB into early
preclinical TB and symptomatic TB, to capture the variation in in-
fectiousness associated with stage of disease in addition to a resistance-
associated fitness cost (Kendall et al., 2017).
Further stratification of active TB into six compartments was un-
dertaken in two models (Kendall et al., 2015; Cohen and Murray, 2004).
A theoretical model of MDR-TB fitness characterised active TB com-
partment as detected or undetected, and furthered stratified as DS-TB,
unfit MDR-TB or fit MDR-TB, assuming unfit MDR-TB to be the least
infectious followed by fit MDR-TB and DS-TB (Cohen and Murray,
2004). The second model sub-divided both DS-TB and MDR-TB into
early stage, active TB and TB on treatment (Kendall et al., 2015). This
model assumed infectiousness variation by stage with early-stage TB
the least infectious followed by TB on treatment. Further stratification
of active TB into nine (Trauer et al., 2016b), 24 (Salje et al., 2014) and
28 (Sachdeva et al., 2015) compartments was used in models that in-
tegrated detection, treatment, HIV and smear-statuses with drug sus-
ceptibility status.
3.3.6. Health system-related factors
3.3.6.1. Detection and treatment. Nineteen TB models stratified the
infectious compartment by diagnosis status (Okuonghae and Aihie,
Y.A. Melsew, et al. Epidemics 30 (2020) 100374
6
Downloaded for Anonymous User (n/a) at James Cook University from ClinicalKey.com.au by Elsevier on May 06, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
2008; Okuonghae and Ikhimwin, 2016; Okuonghae and Korobeinikov,
2007; Okuonghae and Omosigho, 2011; Salomon et al., 2006; Sharomi
et al., 2008; Hickson et al., 2011; Moualeu et al., 2015; Bowong and
Alaoui, 2013; Legrand et al., 2008; Melnichenko and Romanyukha,
2009; Moualeu et al., 2014; Moualeu-Ngangue et al., 2015;
Mushayabasa and Bhunu, 2013; Perelman et al., 2004; Liu et al.,
2008; Moualeu et al., 2018; Okuonghae and Aihie, 2010; Moualeu
et al., 2016). These models employed different assumptions regarding
the greater infectiousness of undetected cases compared to those
receiving treatment. Ten of these models sub-divided the active TB
compartment into two compartments, detected and undetected,
employing Structure A or Structure B (Okuonghae and Aihie, 2008;
Okuonghae and Ikhimwin, 2016; Okuonghae and Korobeinikov, 2007;
Okuonghae and Omosigho, 2011; Sharomi et al., 2008; Bowong and
Alaoui, 2013; Moualeu et al., 2014; Mushayabasa and Bhunu, 2013;
Moualeu et al., 2018; Okuonghae and Aihie, 2010). Further
stratification into three compartments as provided by Structure J was
employed in four models, three of which stratified active TB as
diagnosed, lost to follow-up and undiagnosed infectious, with the
assumption that undiagnosed individuals were most infectious
followed by lost to follow-up (Moualeu et al., 2015; Moualeu-
Ngangue et al., 2015; Moualeu et al., 2016). A theoretical model of
global TB dynamics with the same compartmental structure stratified
active TB as infectious treated, infectious untreated and non-infectious,
with the assumption that untreated cases were seven times more
infectious than patients under treatment (Liu et al., 2008).
A further four models implemented Structure G to divide active TB
into four compartments based on detection status and other factors
(Hickson et al., 2011; Legrand et al., 2008; Melnichenko and
Romanyukha, 2009; Perelman et al., 2004). A model of HIV/TB coin-
fection included nine compartments based on detectability (a function
of geographical location, local health services, and case-finding effort,
as well as health seeking behaviour and intensity of symptoms), smear
and treatment status, with the assumption that smear-positives were the
most infectious and patients treated in high-quality treatment programs
are non-infectious (Salomon et al., 2006).
3.3.6.2. Place of treatment. A model evaluating alternative TB
treatment strategies in China used the place of treatment as a
stratification factor and employed Structure C with the assumption
that patients treated at home were more infectious than patients treated
in hospitals (Huo and Zou, 2016). Similarly, a model employing
Structure A assumed only hospitalised patients received treatment,
thereby implying a higher level of infectiousness for non-hospitalised
individuals with active TB (Zhang et al., 2015).
4. Discussion
Although the infectiousness of individuals with TB is known to be
profoundly heterogeneous, with the epidemic significantly contributed
to by a small group of highly infectious, the great majority of published
TB models did not incorporate this phenomenon in any way. The in-
fectiousness of individuals with active TB depends on their ability to
release aerosolised droplets with sufficient bacilli concentrations
(Turner et al., 2017). This process is particularly heterogeneous in the
case of TB, due to associated risk factors such as the anatomical site of
TB disease, demographic characteristics, behavioural characteristics
and other co-morbidities (Melsew et al., 2018a). Moreover, instances of
very extensive transmission ofMtb have been reported from case studies
(Curtis et al., 1999; Valway et al., 1998), genotypic data analyses
(Ypma et al., 2013) and contact investigation offspring data analyses
(Melsew et al., 2019).
Although heterogeneous infectiousness is the reality for Mtb trans-
mission, this does not necessarily imply that one must always stratify
the active TB compartment irrespective of the modelling objectives. The
principle of parsimony dictates the need to justify any additional
complexity added to models through stratification. In some cases, the
need for stratification is obvious, for example, if the objective of the
model is to predict the relative magnitude of specific types of TB, such
as pulmonary, extrapulmonary, drug-susceptible or multidrug-resistant.
Similarly, if the objective is to evaluate the efficacy of public health
interventions such as targeting children, HIV-positive persons, or pa-
tients with drug-resistant Mtb strains, modellers should consider the
impact of heterogeneity. Similarly, models evaluating diagnostic in-
terventions that have differential sensitivity based on factors associated
with infectiousness, such as smear-status, should usually consider
stratification. It is known that even traditional smear-based case finding
interventions incorporate some targeting towards highly infectious
patients because of the greater sensitivity of smear-based diagnostics
for such patients (Cudahy and Shenoi, 2016). Active case finding in-
terventions that employ very sensitive tools, and so may also detect less
infectious TB patients, should consider the impact of heterogeneous
infectiousness before claiming transmission reduction on the basis of
the number of cases detected.
Most of the assumptions made by models that have incorporated
heterogeneous infectiousness were broadly consistent with available
epidemiological evidence. In our review, we found that TB models
frequently stratified active TB based on sputum smear-status, which is
consistent with our recent meta-analysis that found that contacts of
smear-positive TB patients were more likely to be infected compared
contacts of smear-negative patients (Melsew et al., 2018a). Positive
sputum smear results are indicative of higher bacillary concentrations
and disease that is in direct communication with the individuals’
airway, such that these individuals are often highly infectious (Ait-
Khaled et al., 2003). Several models also recognised that undetected
active TB cases are typically more infectious than those receiving
treatment. This is consistent with epidemiological studies that have
showed that treatment rapidly reduces patients’ infectiousness soon
after commencement (Lohmann et al., 2012; Otero et al., 2016; Tornee
et al., 2004; Xu et al., 2008). Using HIV co-infection as a factor to
stratify the infectiousness of active TB cases is also broadly supported
by meta-analysis results that found contacts exposed to HIV-positive TB
patients had a 55% reduced risk of infection compared to those exposed
to HIV-negative patients, although there were considerable differences
between the individual studies (Cayla et al., 1996; Melsew et al.,
2018b). There is also some evidence to support the higher infectious-
ness of smokers compared to non-smokers (Lohmann et al., 2012;
Huang et al., 2014; Singh et al., 2005), although there is no strong
epidemiological evidence that TB patients with co-morbid diabetes
mellitus have increased infectiousness (Grandjean et al., 2015). Al-
though evidence shows that drug-resistant strains are typically less
transmissible than drug-susceptible strains, the overall fitness of the
strain depends on both the transmission rate and duration of the in-
fectious period. The poorer rates of MDR-TB diagnosis and so longer
periods of infectiousness may offset the fitness cost, such that there is
no clear consensus on the impact of drug resistance on TB transmission
(Luciani et al., 2009; Cohen et al., 2003).
Models vary in regard to their assumptions concerning conversion
from non-infectious states or states with limited infectiousness to more
infectious forms of disease. Most heterogeneous models did not simu-
late this conversion, but rather assumed that individuals immediately
became smear-positive or negative at the point of disease activation. Of
those that did allow for this transition phenomenon, most models as-
sumed smear-negatives could progress to smear-positivity with time.
Active TB disease progression can be viewed as a dynamic continuum,
with individuals progressing from a less infectious stage of disease to a
more highly infectious stage as tissue damage increases (Pai et al.,
2016). However, it is impossible to quantify this phenomenon as it is
unethical to observe the natural history of untreated TB (Tiemersma
et al., 2011). Nevertheless, models consistently assumed such small
parameter values for the rates governing this transition as to be negli-
gible, such that if this process is epidemiologically important then past
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models are unlikely to be fully capturing it.
The impact of heterogeneous infectiousness in transmission dy-
namic models can be explored through the basic reproduction number,
Ro, with marked reductions in R0 potentially achievable by targeting
control measures towards a small proportion of the population that are
highly infectious (Trauer et al., 2018; Matthews et al., 2006). Increases
in heterogeneous infectiousness may not necessarily lead to epidemics
of a greater size for a given Ro although local outbreaks may act as
driving sources of sustained disease burden (Andersson and Britton,
1998; Miller, 2007a; Miller, 2007b). As global TB control targets
elimination, the phenomenon of heterogeneous infectiousness is likely
to become more apparent, increasingly requiring TB models to in-
corporate heterogeneous infectiousness assumptions.
5. Conclusions
Given the evidence of extensive heterogeneity in the infectiousness
of individuals with TB, there exists an argument for the stratification of
active TB states by infectiousness in models. The main consideration for
assuming heterogeneous infectiousness and thus stratifying active TB
based on infectiousness is the objective of the model; in general, when
the objective of the model is to evaluate effectiveness of targeted public
health interventions or evaluation of diagnostic tools, modellers should
consider incorporating heterogeneous infectiousness. Consensus has not
been reached as to the optimal approach to stratifying TB models to
capture the considerable heterogeneity in infectiousness between in-
dividuals, and it may be that there is no a single approach that will suit
all epidemiological scenarios and research questions.
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